Effective hepatic blood flow during cardiopulmonary bypass

W. W. Hampton, M. C. Townsend, W. J. Schirmer, D. M. Haybron and D. E. Fry
Department of Surgery, Case Western Reserve University, Cleveland, Ohio.

Hepatic dysfunction following cardiopulmonary bypass (CPB) is a relatively frequent finding, and jaundice occurring after CPB is associated with an increased mortality rate. Post-CPB jaundice may be a consequence of inadequate liver perfusion during CPB. To evaluate the potential impact of CPB on effective hepatic blood flow, 10 patients undergoing CPB for cardiac procedures were studied. Effective hepatic blood flow was measured in each patient during the operative procedure but before institution of CPB and during CPB as well. Effective hepatic blood flow was measured by the galactose clearance technique. Blood lactate and pyruvate levels were also measured before and during CPB. During CPB, effective hepatic blood flow was consistently reduced by an average of 19%. Although for most patients this reduction seems well tolerated, in a minority of patients it may contribute to postoperative hepatic dysfunction.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Gastrointestinal Dysfunction Following Cardiac Surgery
Ohri and Velissaris
Perfusion 2006;21:215-223.
 

Autoregulation of human jejunal mucosal perfusion during cardiopulmonary bypass.
Nygren et al.
Anesth. Analg. 2006;102:1617-1622.
ABSTRACT | FULL TEXT  

Abdominal Organ Injury After Cardiac Surgery
Hessel
SEMIN CARDIOTHORAC VASC ANESTH 2004;8:243-263.
ABSTRACT  

Adverse Gastrointestinal Complications After Cardiopulmonary Bypass: Can Outcome Be Predicted from Preoperative Risk Factors?
McSweeney et al.
Anesth. Analg. 2004;98:1610-1617.
ABSTRACT | FULL TEXT  

Splanchnic Blood Flow in Low-Flow States
Jakob
Anesth. Analg. 2003;96:1129-1138.
ABSTRACT | FULL TEXT  

Plasma propofol concentration and EEG burst suppression ratio during normothermic cardiopulmonary bypass
Yoshitani et al.
Br J Anaesth 2003;90:122-126.
ABSTRACT | FULL TEXT  

Tolerance to ACE inhibitors after cardiac surgery
Manche et al.
Eur. J. Cardiothorac. Surg. 1999;15:55-60.
ABSTRACT | FULL TEXT  

Enhancing liver blood flow after cardiopulmonary bypass: the effects of dopamine and dopexamine
Sharpe et al.
Perfusion 1999;14:29-36.
ABSTRACT  

Effects of flow types in cardiopulmonary bypass on gastric intramucosal pH
Hamulu et al.
Perfusion 1998;13:129-135.
ABSTRACT  

HEPATIC BLOOD FLOW DURING CARDIOPULMONARY BYPASS OPERATIONS: THE EFFECT OF TEMPERATURE AND PULSATILITY
Mathie et al.
J. Thorac. Cardiovasc. Surg. 1997;114:292-293.
FULL TEXT  

Effects of Dopamine on Liver Blood Flow in Children With Congenital Heart Disease
Mitchell et al.
Ann. Thorac. Surg. 1995;60:1741-1744.
ABSTRACT | FULL TEXT  

The validation of auricular densitometry for indocyanine green clearance measurement of hepatic blood flow during and after cardiopulmonary bypass in children
Mitchell et al.
Perfusion 1995;10:197-208.
ABSTRACT  

The effects of congenital heart disease and cardiac surgery on I iver blood flow in children
Mitchell et al.
Perfusion 1995;10:210-218.
ABSTRACT  

Postoperative Abdominal Complications in Cardiopulmonary Bypass Patients: A Case-Controlled Study
Ott et al.
Ann. Thorac. Surg. 1995;59:1210-1213.
ABSTRACT | FULL TEXT